Cargando…
Immunocytochemical Characterization of Alzheimer’s Disease Hallmarks in APP/PS1 Transgenic Mice Treated with a New Anti-Amyloid-β Vaccine
INTRODUCTION: APP/PS1 double-transgenic mouse models of Alzheimer’s disease (AD), which overexpress mutated forms of the gene for the human amyloid precursor protein (APP) and presenilin 1 (PS1), have provided robust neuropathological hallmarks of an AD-like pattern at early ages. This study aimed t...
Autores principales: | Carrera, Ivan, Etcheverria, Ignacio, Li, Yi, Fernandez-Novoa, Lucia, Lombardi, Valter, Vigo, Carmen, Palacios, Hector H., Benberin, Valery V., Cacabelos, Ramon, Aliev, Gjumrakch |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
University Library System, University of Pittsburgh
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5960902/ https://www.ncbi.nlm.nih.gov/pubmed/29805876 http://dx.doi.org/10.5195/cajgh.2013.119 |
Ejemplares similares
-
Immunocytochemical Characterization of Alzheimer Disease Hallmarks in APP/PS1 Transgenic Mice Treated with a New Anti-Amyloid-β Vaccine
por: Carrera, Iván, et al.
Publicado: (2013) -
Vaccine Development to Treat Alzheimer's Disease Neuropathology in APP/PS1 Transgenic Mice
por: Carrera, Iván, et al.
Publicado: (2012) -
A Comparative Evaluation of a Novel Vaccine in APP/PS1 Mouse Models of Alzheimer's Disease
por: Carrera, Iván, et al.
Publicado: (2015) -
Prevention of Chronic Experimental Colitis Induced by Dextran Sulphate Sodium (DSS) in Mice Treated with FR91
por: Lombardi, Valter R. M., et al.
Publicado: (2012) -
The GRK2 Overexpression Is a Primary Hallmark of Mitochondrial Lesions during Early Alzheimer Disease
por: Obrenovich, Mark E., et al.
Publicado: (2009)